We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Expanding European Market for Immunodiagnostics

By Labmedica staff writers
Posted on 11 Oct 2006
The immunodiagnostics market in Europe is expanding because of constant improvements in instrument capabilities and broad test menus. More...
A recent report from Frost & Sullivan (Palo alto, CA, USA) has found that the European immunodiagnostics automation markets earned revenues of U.S.$425 million in 2005, and estimates that this will reach $599.7 million in 2012.

The wide range of integrated analyzers has significantly improved profitability and revenue returns, but declining reimbursement rates and the lack of common industry standards for immunodiagnostic tests may hinder market expansion. This situation will compel in vitro diagnostics (IVD) manufacturers to design innovative strategies.

The need to accommodate and automate increasing test menus is motivating vendors to develop instrument capabilities that can meet modern clinical needs. In addition, growing volumes of tests are obliging laboratories to switch to high throughput systems, which are supporting the adoption and replacement of immunodiagnostic systems.

"The identification of new disease states and expanding test menus are key to market growth,” noted Frost & Sullivan research associate A.K. Arun. "An emphasis on achieving enhanced quality of healthcare is driving researchers to develop cost-effective diagnostic tests that provide better clinical outcomes, propelling the placement rates of analyzers.”

Although the need for, and value of, standardization and validation of assays has been recognized, it will still be necessary to accelerate this process in order to regulate immunodiagnostic procedures. The IVD industry needs to liaise with healthcare officials, the government, and medical communities to highlight the importance of diagnostic tests and appropriate reimbursement.



Related Links:
Frost & Sullivan

New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.